[1] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
[2] |
YANG Jun, KANG Wei, ZHONG Wuning, ZHAO Xin.
Predictive value of radiomics model based on cone-beam breast CT images for pathological complete response of neoadjuvant therapy in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 103-108.
|
[3] |
ZHANG Xiaomeng, WANG Yue, WAN Qiaoqin.
Summary of evidence for the management of drug-related symptoms during endocrine therapy in breast cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 615-621.
|
[4] |
ZHANG Wenhai, LIAN Bin, HOU Qinhan, LIANG Xinguang, YANG Qiujiao, LIANG Ling, CHEN Binjie, WEI Changyuan.
Construction and validation of nomogram model for predicting the relatively long-term survival of metastatic breast cancer based on SEER database
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 454-461.
|
[5] |
XIE Changquan, HE Fengyi, LU Guodong, LI Qiuyun.
Andrographolide combined with doxorubicin induces cell death in breast cancer cell via ROS-dependent DNA damage
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 302-307.
|
[6] |
WU Hualing, LIN Qing .
Analysis of clinical and dosimetric factors related to radiation pneumonitis after intensity-modulated radiotherapy in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 327-331.
|
[7] |
LUO Xianting, FENG Yimin, ZHOU Jing, XIAO Lei, YIN Jiayu, ZHAO Xin, SU Danke.
Value of Kaiser score-based MRI feature nomogram model in preoperative prediction of vascular invasion in mass breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 332-338.
|
[8] |
LEI Lei, XUE Xiaojing, SHI Qiulin, WANG Xiaoyan, FENG Gang, YANG Lijuan, JIANG Yuan, LIU Ran.
Summary of the best evidence for non?drug prevention and management of sleep disorders in breast cancer survivors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 223-229.
|
[9] |
WANG Yong, ZHOU Yuling, ZHOU Qionghui, ZENG Biao, HU Ying.
Application of 3D printing compensation film in postoperation radiotherapy of immediate breast reconstruction for breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 96-100.
|
[10] |
GAO Fangfang, CHEN Binjie, TAN Qixing, HUANG Zhen, LU Weifeng, WEI Changyuan.
Analysis of risk factors of prognosis,recurrence and metastasis of breast cancer patients with non-pathologic complete response after neoadjuvant chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 650-656.
|
[11] |
WU Lingjun, LIANG Cong, HUANG Ju, LI Jialin, HUANG Songling, CHEN Zhuying, HE Ping.
Inhibitory effect of compound cremastra appendiculata on growth of human breast cancer MDA-MB-231 cell xenografts in nude mice and a network pharmacological analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 298-303.
|
[12] |
JIAO Kailun, YU Richeng, HE Tao .
Combined effect of ATRA and SAHA on transplanted tumor of human breast cancer cell MCF-7 in nude mice
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 149-156.
|
[13] |
SONG Qiulu, HUANG Juanchan, LIN Chunxiang, WEI Kexuan, TANG Min, ZHAO Wei.
Effect of SLC1A5 on the radiosensitivity of triple negative breast cancer MDA-MB-231 cells and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 163-169.
|
[14] |
MA Jingyi, DONG Xuefan, TIAN Jianli, LI Yang, SHI Limin.
Summary of the best evidence for non⁃pharmacological intervention in breast cancer patients with osteoporosis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(6): 659-664.
|
[15] |
GAN Lu, FANG Qiong.
Status and influencing factors of sexual dysfunction in young breast cancer patients during endocrine therapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 558-564.
|